FDA ALTERNATIVE BREAST PROSTHESES DRAFT GUIDANCE ON TESTING
This article was originally published in The Gray Sheet
Executive Summary
FDA ALTERNATIVE BREAST PROSTHESES DRAFT GUIDANCE ON TESTING outlines four potential options for postmarket epidemiologic studies of nonsilicone gel-filled implants, in decreasing order of cost per study subject: a "prospective center-based cohort study of implant recipients"; a "medical record-based retrospective cohort study of implant recipients"; a "questionnaire screening of implant recipients"; and a "mortality screen." The draft guidance will be a topic of discussion at an Oct. 21 FDA workshop in Washington, D.C. ("The Gray Sheet" Sept. 5, In Brief).
You may also be interested in...
Atlas Biomed Unlocking Japan’s OTC Market With Direct-To-Consumer DNA And Microbiome Tests
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
Hair Supplement Linked To Cases Of Severe Hepatitis In France
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
AZ Will Sideline ‘Lucky Mistake’ Data To Secure COVID-19 Vaccine Approval
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: